SMARCAD1: A Potential Drug Target and Biomarker (G56916)

Target Name: SMARCAD1

NCBI ID: G56916

SMARCAD1: A Potential Drug Target and Biomarker

SMARCAD1, short for SMARCs associated with adenosine signaling, is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of adenosine signaling, which is a critical signaling pathway that plays a crucial role in various physiological processes, including cardiovascular function, immune responses, and neurotransmission. SMARCAD1 has also been implicated in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, it is a promising drug target and biomarker for a variety of therapeutic approaches.

The discovery and characterization of SMARCAD1

SMARCAD1 was first identified as a new gene in the database using a technique called transcriptome-based comparative genomics. This approach allowed researchers to compare the expression patterns of SMARCAD1 between different tissues and cells to identify new genes that were expressed at different levels. Initial studies identified that SMARCAD1 was expressed in a variety of tissues and cells, including brain, heart, liver, and pancreas. It was also found to be highly expressed in cancer tissues, which suggests that it may be a potential drug target for cancer therapies.

Functional characterization of SMARCAD1

SMARCAD1 is a protein that is characterized by a unique domain structure that is composed of a long alpha-helix, a short beta-sheet, and a long terminal extension. This structure is thought to give SMARCAD1 its unique stability and stability, as well as its ability to interact with other proteins. SMARCAD1 is also known for its ability to form a complex with the protein OSBP (open reading frame binding protein), which is a known regulator of SMARCAD1's activity. This interaction between SMARCAD1 and OSBP suggests that SMARCAD1 may play a role in the regulation of gene expression and protein synthesis.

SMARCAD1's role in adenosine signaling

SMARCAD1 is a key regulator of adenosine signaling, which is a critical signaling pathway that plays a crucial role in various physiological processes. Adenosine is a naturally occurring compound that plays a vital role in the regulation of inflammation, immune responses, and neurotransmission. It is produced by the endoplasmic reticulum and is degraded by the endosomal system. SMARCAD1 is involved in the regulation of adenosine's effects on various cellular processes, including the regulation of inflammation, cell survival, and neurotransmission.

SMARCAD1's role in cancer

SMARCAD1 has been implicated in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Studies have shown that SMARCAD1 is highly expressed in cancer tissues and that its levels are often increased in comparison to adjacent normal tissues. This increase in SMARCAD1 levels has been associated with the development of a variety of negative outcomes in cancer patients, including increased cancer cell proliferation, invasiveness, and metastasis.

SMARCAD1's potential as a drug target

SMARCAD1's role in adenosine signaling and its involvement in cancer make it a promising drug target for a variety of therapeutic approaches. Researchers are currently working to identify small molecules that can inhibit SMARCAD1's activity and to determine the mechanisms by which these molecules will interact with the protein . Potential drug targets for SMARCAD1 include small molecules that can inhibit the interaction between SMARCAD1 and OSBP, as well as inhibitors of SMARCAD1's activity in the regulation of adenosine signaling.

SMARCAD1 as a biomarker

SMARCAD1 has also been identified as a potential biomarker for several types of cancer, including breast, ovarian, and prostate cancer. This is because the levels of SMARCAD1 have been shown to be elevated in cancer tissues compared to adjacent normal tissues. Researchers are currently working to develop methods for the detection and quantification of SMARCAD1 in cancer tissues, with the goal of using SMARCAD1 as a diagnostic or

Protein Name: SWI/SNF-related, Matrix-associated Actin-dependent Regulator Of Chromatin, Subfamily A, Containing DEAD/H Box 1

Functions: DNA helicase that possesses intrinsic ATP-dependent nucleosome-remodeling activity and is both required for DNA repair and heterochromatin organization. Promotes DNA end resection of double-strand breaks (DSBs) following DNA damage: probably acts by weakening histone DNA interactions in nucleosomes flanking DSBs. Required for the restoration of heterochromatin organization after replication. Acts at replication sites to facilitate the maintenance of heterochromatin by directing H3 and H4 histones deacetylation, H3 'Lys-9' trimethylation (H3K9me3) and restoration of silencing

More Common Targets